Targeting the various aspects of the metabolic syndrome may provide a means for preventing the development of diabetic neuropathy, authors of a review suggested.
CHICAGO -- British patients followed after starting on glitazone drugs for type 2 diabetes were significantly more likely to develop bladder cancer than those taking sulfonylurea agents.
Changes in diameter of the tiny blood vessels in the retina predicted the later development cardiovascular disease in African-Americans with type 1 diabetes, researchers found.
Cystic fibrosis patients with the most common CF mutation had improved lung function with a two-drug combination. Also this week: a CDC advisory group adopts formal evidence-grading standards.
You’re just a "tweet" away. Follow us on Twitter to receive news and helpful updates throughout the day.
Sharing information with friends and family is the number one reason for social media outlets. Check out our Facebook page and become a fan!